Acorn Bioventures, L.P. - Aug 14, 2025 SCHEDULE 13G/A Report for Y-mAbs Therapeutics, Inc. Common stock, par value $0.0001 per share (YMAB)

Filing Manager
Acorn Bioventures, L.P.
Reporting Manager
Anders Hove
Security
Y-mAbs Therapeutics, Inc. Common stock, par value $0.0001 per share
Symbol
YMAB
Shares outstanding
44.2M shares
Disclosed Ownership
3.1M shares
Ownership
7%
Form type
SCHEDULE 13G/A
Date filed
8/15/2025, 10:31 AM
Date of event
Aug 14, 2025
Next filing
Aug 20, 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ACORN BIOVENTURES, L.P. 3% 1.3M 0 1.3M Anders Hove Manager of General Partner
ACORN CAPITAL ADVISORS GP, LLC 3% 1.3M 0 1.3M Anders Hove Manager
ACORN BIOVENTURES 2, L.P. 4% 1.79M 0 1.79M Anders Hove Manager of General Partner
Acorn Capital Advisors GP 2, LLC 4% 1.79M 0 1.79M Anders Hove Manager
Anders Hove 7% 3.1M 0 3.1M Anders Hove Individually